Breaking: Expert Perspective on Trial Results of Advanced Prostate Cancer Vaccine

4/28/2009 - Webcast

Guests Include:

Christopher Amling, M.D., F.A.C.S.
Dr. Christopher Amling is head of the Division of Urology in the Department of Surgery, OHSU School of Medicine, OHSU Knight Cancer Institute. Dr. Amling is an expert in advanced minimally invasive management of urologic diseases, including robotic surgery for prostate and bladder cancer, and prostate cancer and outcomes research. He is credited with developing innovative evaluation tools to enhance the education of surgical residents and has authored numerous scholarly articles that have improved methods for diagnosing and treating prostate cancer. Dr. Amling is a diplomate of the American Board of Urology; fellow in the American College of Surgeons; member of the American Urologic Association; president-elect of the Society of University Urologists; and a member of the editorial board of the Journal of Urology; reviewer for the Journal of the American Medical Association and the Journal of Urology and Cancer, as well as several other publications and honors.

Download Streaming Audio